REFERENCE
Yamazaki Y, Kitagawa Y, Hata H, Abe T, Murai C, Shiga T, Tamaki N.Use of FDG PET to evaluate hyperbaric oxygen therapy for bisphosphonate-related osteonecrosis of the jaw. Clinical Nuclear Medicine 35: 590-591, Aug 2010. Available from: URL: http://dx.doi.org/10.1097/rlu.0b013e3181e4df11 - Japan
Rights and permissions
About this article
Cite this article
Alendronic acid. React. Wkly. 1319, 9 (2010). https://doi.org/10.2165/00128415-201013190-00028
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201013190-00028